Anzeige
Mehr »
Login
Donnerstag, 26.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40VJX | ISIN: US89357L4023 | Ticker-Symbol:
NASDAQ
26.12.24
22:00 Uhr
3,890 US-Dollar
+0,330
+9,27 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TRANSCODE THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
TRANSCODE THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur TRANSCODE THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrTranscode Therapeutics, Inc. - 8-K, Current Report-
18.12.TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial59Approval given after Safety Review Committee (SRC) review of safety data from the three patients comprising Cohort 2 No significant safety or dose limiting toxicities...
► Artikel lesen
12.12.Transcode Therapeutics stock hits 52-week low at $6.891
12.12.Peering Into TransCode Therapeutics' Recent Short Interest1
06.12.Transcode Therapeutics, Inc. - S-1, General form for registration of securities10
TRANSCODE THERAPEUTICS Aktie jetzt für 0€ handeln
02.12.Transcode Therapeutics, Inc. - 8-K, Current Report1
02.12.Why TransCode Therapeutics (RNAZ) Stock Is Diving3
02.12.TransCode Therapeutics to execute 1-for-33 reverse stock split on Dec 42
29.11.TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split166BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA...
► Artikel lesen
27.11.TransCode Therapeutics announces $8M private offering2
27.11.TransCode Therapeutics, Inc. Announces $8 Million Private Placement2
25.11.Why Transcode Therapeutics (RNAZ) Stock Is Moving2
25.11.TransCode Therapeutics to conduct reverse stock split14
25.11.TransCode Therapeutics approves reverse stock split3
25.11.TransCode Therapeutics, Inc.: TransCode Therapeutics Announces 1-for-33 Reverse Stock Split165BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA...
► Artikel lesen
25.11.Transcode Therapeutics, Inc. - 8-K, Current Report-
06.11.Transcode Therapeutics, Inc. - 8-K, Current Report9
05.11.TransCode Therapeutics maintains Nasdaq listing with conditions14
05.11.TransCode Therapeutics gets Nasdaq extension to regain compliance8
05.11.TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance110BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced...
► Artikel lesen
Seite:  Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1